Stocktoria
CVRx, Inc. CVRX
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-06-30
CVRx, Inc. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $56.7M | $51.3M | $39.3M | $22.5M | $13.0M | $6.1M |
| Gross profit | $48.3M | $43.0M | $33.0M | $17.5M | $9.4M | $4.6M |
| R&D expense | $11.1M | $11.1M | $11.6M | $10.0M | $7.5M | $6.4M |
| SG&A expense | $88.5M | $91.3M | $64.5M | $50.0M | $27.9M | $9.7M |
| Operating income | -$51.3M | -$59.5M | -$43.1M | -$42.5M | -$26.0M | -$11.5M |
| Interest expense | — | — | $1.8M | $165,000 | $2.2M | $2.5M |
| Income tax | -$18,000 | $55,000 | $147,000 | $109,000 | $91,000 | $85,000 |
| Net income | -$53.3M | -$60.0M | -$41.2M | -$41.4M | -$43.1M | -$14.1M |
| EPS (diluted) | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 | — |
| Operating cash flow | -$40.2M | -$39.1M | -$39.0M | -$42.7M | -$27.7M | -$16.1M |
| Free cash flow | -$40.8M | -$40.5M | -$39.6M | -$43.4M | -$28.9M | -$16.4M |
| Cash & equivalents | $75.7M | $105.9M | $90.6M | $106.2M | $142.1M | $59.1M |
| Inventory | $12.2M | $12.1M | $11.0M | $7.0M | $3.9M | $3.3M |
| Total assets | $104.8M | $133.4M | $115.2M | $124.9M | $152.5M | $64.8M |
| Total liabilities | $65.5M | $62.4M | $39.3M | $15.8M | $6.6M | $28.0M |
| Shareholders' equity | $39.3M | $71.1M | $75.9M | $109.2M | $146.0M | -$293.2M |
Growth · year-over-year · Revenue CAGR 56.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | +10.4% | +30.5% | +74.9% | +72.4% | +115.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.